Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Are your medical devices safe? New hacker group targeting x-ray, MRI equipment

Orangeworm, an aggressive group of hackers, is targeting medical devices of healthcare providers with a new malware. The malware, called Kwampirs, is a “backdoor Trojan that provides the attackers with remote access to the compromised computer,” the cybersecurity firm Symantec reported this week.

Thumbnail

MR imaging a ‘suitable alternative’ to CT when evaluating patients for acute appendicitis

Physicians regularly turn to CT to evaluate patients who arrive at a hospital emergency department (ED) due to acute appendicitis. According to a new study published in Radiology, the diagnostic accuracy of MR imaging compares favorably to that of CT when diagnosing acute appendicitis, meaning patients can receive the same level of care without the ionizing radiation exposure.

MITA: NEMA service standard now covers all medical devices

The Medical Imaging & Technology Alliance (MITA) is expanding the scope of its NEMA American National Standard for Servicing Medical Imaging Devices to cover all medical devices as opposed to just medical imaging technologies.

Image reconstruction algorithm, MRI-derived heart strain values can aid prognosis in amyloidosis patients

Recent research found strain parameters taken from a cine MRI-based deformable registration algorithm (DRA) can determine the severity of amyloid buildup in the heart and may provide prognostic information on patients with light-chain (AL) amyloidosis.

Thumbnail

False-positives increase follow-up screening participation

Patients who receive a false-positive breast or prostate cancer screening are more likely to continually participate in follow-up screenings, according to a study published in Cancer.

Thumbnail

SNMMI recommends Aetna reverse 2 PET coverage decisions

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a statement recommending Aetna reverse its decision not to cover the use of gallium Ga 68 dotatate PET or fluciclovine F18 PET for treating cancer patients.

Thumbnail

SNMMI urges Aetna to alter coverage of 2 PET tracers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) addressed two letters to Aetna recommending the health insurance giant alter its radiopharmaceutical coverage policy to include PET imaging agents dotatate and fluciclovine.

Thumbnail

Patient navigation programs—despite extra costs—narrow disparities in underserved populations

Patient navigation programs are being integrated into more healthcare systems to reduce care disparities, according to an article published online in the Journal of the American College of Radiology.